News

Dr. James O’Keefe and Dr. Andrew Sauer with Saint Luke’s Mid America Heart Institute talk about new research that is changing the way obesity is treated and understood.

A local man with heart failure who was told numerous times he only had months to live gets a second chance at life after treatment at Saint Luke's.

When Debbie O’Neal was diagnosed with heart failure at 75, she feared her life was ending. She was the same age that her mother had been when she died of heart disease.

James O’Keefe, MD, a co-investigator of this study, and director of preventive cardiology at Saint Luke’s Mid America Heart Institute, talked with KCTV about these new findings.

Dr. James O’Keefe, a co-investigator of this study, explains why GLP-1 medications may be uniquely effective in addressing addictive behaviors like recreational drug use, alcohol consumption, and food cravings.

This week we're talking with Dr. Sanjaya Gupta, cardiologist at Saint Luke’s Mid America Heart Institute, about the latest treatment options for this underdiagnosed heart condition.

Art Still has ATTR amyloidosis, an inherited heart condition that dramatically impacts Black men and the former Kansas City Chiefs defensive end wants to raise awareness.

Saint Luke's is spreading awareness, love, and humor this season with a series of heartfelt valentine messages, reminding people to take care of their own hearts.

"Jill asked, 'If this was your father where would you take him?' And [the doctor] said, 'Saint Luke’s in Kansas City.' And Saint Luke’s saved my life."

Dr. Adnan Chhatriwalla, interventional cardiologist at Saint Luke’s Mid America Heart Institute, talks about symptoms of heart valve disease, treatment, and keys to long-term heart health.